NEWS

PRESS RELEASES

JULY 30, 2020

Melt Pharmaceuticals Enters the Clinical Stage of MELT-100 Development

FEBRUARY 13, 2019

Melt Pharmaceuticals Improves Patent Estate for Sublingual Non-Opioid Pain and Sedation Formulations

FEBRUARY 5, 2019

Harrow Health Announces $11 Million Series A Financing for Melt Pharmaceuticals Subsidiary

RELATED NEWS

CMS proposes Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System changes for 2019 (CMS-1695-P)

MORE